SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-024516
Filing Date
2024-06-20
Accepted
2024-06-20 16:15:17
Documents
17
Period of Report
2024-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43182
2 ex4-1.htm EX-4.1 113477
3 ex4-2.htm EX-4.2 109731
4 ex10-1.htm EX-10.1 237024
5 ex99-1.htm EX-99.1 17037
  Complete submission text file 0001493152-24-024516.txt   798515

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE thar-20240618.xsd EX-101.SCH 3021
7 XBRL LABEL FILE thar-20240618_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE thar-20240618_pre.xml EX-101.PRE 22363
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3791
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 241056395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)